Kumiai Chemicals <4996>
Announced a revision to the financial estimates for the fiscal year ending October 2024. Revenue increased from 155 billion yen to 161 billion yen, and operating profit was revised upwards from 10 billion yen to 11.5 billion yen. Due to increased shipments of overseas agrochemicals including the herbicide for field crops 'Axive,' the company expects an increase in revenue and operating profit compared to the revised estimates disclosed on June 4.
PKSHA <3993>
Having strengthened a rebound trend since hitting a recent low of 3415 yen on November 22, the stock has surpassed the 200-day moving average recently and was bought up to 4225 yen the previous day. Although profit-taking followed thereafter, the 200-day moving average hovering around 4030 yen is being recognized as a support level. The stock has broken above the 52-week line that had been acting as resistance in the weekly chart, indicating a potential reversal from the adjustment trend that peaked at 6850 yen in February.